Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Edesa Biotech, Inc. (EDSA)
Sector: Healthcare; Industry: Biotechnology

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the development and advancement of treatments for dermatological and gastrointestinal indications. Edesa Biotech, Inc. has a collaborative research project with the National Research Council of Canada to develop novel immunotherapies for vitiligo, as well as other indications; and Light Chain Bioscience for the development and commercialization of two Phase 2-ready biologic drug candidates for various therapeutic, prophylactic, and diagnostic applications. The company was founded in 2015 and is headquartered in Markham, Canada.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-03-29 Nijhawan Pardeep Chief Executive Officer Buy 2,000 $5.23 $10,460 No
2021-03-25 Nijhawan Pardeep Chief Executive Officer Buy 3,000 $5.25 $15,750 No
2021-03-25 Brooks Michael J President Buy 3,500 $5.19 $18,165 No
2021-03-24 Brooks Michael J President Buy 4,500 $5.08 $22,860 No
2021-03-24 Nijhawan Pardeep Chief Executive Officer Buy 5,000 $5.16 $25,800 No
2021-02-18 OAKES FRANK R. Director Sell 7,992 $7.25 $57,942 No
2020-05-27 Brooks Michael J President Buy 2,500 $3.00 $7,498 No
2020-05-26 Nijhawan Pardeep Chief Executive Officer Buy 3,000 $2.98 $8,939 No
2020-03-17 Nijhawan Pardeep Chief Executive Officer Buy 5,000 $1.87 $9,373 No
2020-01-08 van der Velden Peter 10%-Owner, Director Buy 140,625 $3.20 $450,000 Yes
2020-01-08 Sistilli Carlo Director Buy 2,436 $4.11 $10,012 Yes
2020-01-08 JOHNSON LORIN K Director Buy 8,524 $4.11 $35,034 Yes
2020-01-08 Brooks Michael J President Buy 1,827 $4.11 $7,509 Yes
2019-09-11 OAKES FRANK R. Director Sell 1,809 $5.72 $10,345 No
2019-03-06 OAKES FRANK R. President & CEO Sell 4,000 $1.25 $5,000 No
2018-10-12 MORSE DANIEL E. Former Director Sell 7,047 $1.31 $9,260 No
2018-10-12 OAKES FRANK R. President & CEO Sell 3,000 $1.31 $3,930 No
2018-03-29 MORSE DANIEL E. Director Sell 4,366 $0.81 $3,515 No
2018-03-12 MORSE DANIEL E. Director Sell 32,300 $0.79 $25,600 Yes

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

Carvana Co (CVNA) - One of the best timed insider buying in the crash is from GARCIA ERNEST C. II 10%-owner of CVNA. Bought at 45 and now with a 100%+ profit.